Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening.
This study investigated both the activity of nisin Z, either encapsulated in liposomes or produced in situ by a mixed starter, against Listeria innocua, Lactococcus spp., and Lactobacillus casei subsp. casei and the distribution of nisin Z in a Cheddar cheese matrix. Nisin Z molecules were visualized using gold-labeled anti-nisin Z monoclonal antibodies and transmission electron microscopy (immune-TEM). Experimental Cheddar cheeses were made using a nisinogenic mixed starter culture, containing Lactococcus lactis subsp. lactis biovar diacetylactis UL 719 as the nisin producer and two nisin-tolerant lactococcal strains and L. casei subsp. casei as secondary flora, and ripened at 7 degrees C for 6 months. In some trials, L. innocua was added to cheese milk at 10(5) to 10(6) CFU/ml. In 6-month-old cheeses, 90% of the initial activity of encapsulated nisin (280 +/- 14 IU/g) was recovered, in contrast to only 12% for initial nisin activity produced in situ by the nisinogenic starter (300 +/- 15 IU/g). During ripening, immune-TEM observations showed that encapsulated nisin was located mainly at the fat/casein interface and/or embedded in whey pockets while nisin produced by biovar diacetylactis UL 719 was uniformly distributed in the fresh cheese matrix but concentrated in the fat area as the cheeses aged. Cell membrane in lactococci appeared to be the main nisin target, while in L. casei subsp. casei and L. innocua, nisin was more commonly observed in the cytoplasm. Cell wall disruption and digestion and lysis vesicle formation were common observations among strains exposed to nisin. Immune-TEM observations suggest several modes of action for nisin Z, which may be genus and/or species specific and may include intracellular target-specific activity. It was concluded that nisin-containing liposomes can provide a powerful tool to improve nisin stability and availability in the cheese matrix.
Benech
R-O
RO
Dairy Research Centre STELA, Université Laval, Québec, PQ, Canada G1K 7P4.
Kheadr
E E
EE
Lacroix
C
C
Fliss
I
I
D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology; D002214:Capsules; D002611:Cheese / Q000032:analysis* / Q000382:microbiology; D016503:Drug Delivery Systems; D005285:Fermentation; D007778:Lactobacillus / Q000187:drug effects; D017045:Lactococcus / Q000187:drug effects; D008081:Liposomes; D008087:Listeria / Q000187:drug effects; D008854:Microscopy, Electron; D009561:Nisin / Q000031:analogs & derivatives* / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D002214:Capsules; D008081:Liposomes; D009561:Nisin; C071364:nisin Z